OT-101
C002 2020 01
Phase 2 small_molecule active
Quick answer
OT-101 for COVID-19 is a Phase 2 program (small_molecule) at Oncotelic Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oncotelic Therapeutics
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active